Edward Libby

Title(s)Associate Physician Diplomate, Medicine
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia. Blood Adv. 2024 04 09; 8(7):1639-1650. Tam CS, Opat S, D'Sa S, Jurczak W, Lee HP, Cull G, Owen RG, Marlton P, Wahlin BE, García-Sanz R, McCarthy H, Mulligan S, Tedeschi A, Castillo JJ, Czyz J, Fernández De Larrea C, Belada D, Libby E, Matous J, Motta M, Siddiqi T, Tani M, Trnený M, Minnema MC, Buske C, Leblond V, Treon SP, Trotman J, Wu B, Yu Y, Shen Z, Chan WY, Schneider J, Allewelt H, Cohen A, Dimopoulos MA. PMID: 38315878; PMCID: PMC11006814.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    2. Birtamimab plus standard of care in light-chain amyloidosis: the phase 3 randomized placebo-controlled VITAL trial. Blood. 2023 10 05; 142(14):1208-1218. Gertz MA, Cohen AD, Comenzo RL, Kastritis E, Landau HJ, Libby EN, Liedtke M, Sanchorawala V, Schönland S, Wechalekar A, Zonder JA, Palladini G, Walling J, Guthrie S, Nie C, Karp C, Jin Y, Kinney GG, Merlini G. PMID: 37366170; PMCID: PMC10644097.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    3. Single-agent belantamab mafodotin in patients with relapsed/refractory multiple myeloma: Final analysis of the DREAMM-2 trial. Cancer. 2023 12 01; 129(23):3746-3760. Nooka AK, Cohen AD, Lee HC, Badros A, Suvannasankha A, Callander N, Abdallah AO, Trudel S, Chari A, Libby EN, Chaudhry M, Hultcrantz M, Kortüm KM, Popat R, Sborov D, Hakim S, Lewis E, Gorsh B, Bhushan B, McKeown A, Gupta I, Opalinska J, Richardson PG, Lonial S. PMID: 37622738; PMCID: PMC11055177.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    4. Zanubrutinib Versus Ibrutinib in Symptomatic Waldenström Macroglobulinemia: Final Analysis From the Randomized Phase III ASPEN Study. J Clin Oncol. 2023 Nov 20; 41(33):5099-5106. Dimopoulos MA, Opat S, D'Sa S, Jurczak W, Lee HP, Cull G, Owen RG, Marlton P, Wahlin BE, Garcia-Sanz R, McCarthy H, Mulligan S, Tedeschi A, Castillo JJ, Czyz J, Fernández de Larrea C, Belada D, Libby E, Matous J, Motta M, Siddiqi T, Tani M, Trnený M, Minnema MC, Buske C, Leblond V, Treon SP, Trotman J, Chan WY, Schneider J, Allewelt H, Patel S, Cohen A, Tam CS. PMID: 37478390; PMCID: PMC10666987.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    5. γ-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, first-in-human trial. Lancet Oncol. 2023 07; 24(7):811-822. Cowan AJ, Pont MJ, Sather BD, Turtle CJ, Till BG, Libby EN, Coffey DG, Tuazon SA, Wood B, Gooley T, Wu VQ, Voutsinas J, Song X, Shadman M, Gauthier J, Chapuis AG, Milano F, Maloney DG, Riddell SR, Green DJ. PMID: 37414012; PMCID: PMC10783021.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCellsCTClinical Trials
    6. Efficacy, safety, and molecular response predictors of oral ixazomib and short-course rituximab in untreated iNHL. Blood Adv. 2023 03 14; 7(5):687-696. Graf SA, Lynch RC, Ujjani CS, Gooley TA, Rasmussen H, Coffey DG, Cowan AJ, Smith SD, Shadman M, Warren EH, Libby EN, Greninger AL, Fromm JR, Gopal AK. PMID: 36385536; PMCID: PMC9984960.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    7. Six-Year Results From RELEVANCE: Lenalidomide Plus Rituximab (R2) Versus Rituximab-Chemotherapy Followed by Rituximab Maintenance in Untreated Advanced Follicular Lymphoma. J Clin Oncol. 2022 10 01; 40(28):3239-3245. Morschhauser F, Nastoupil L, Feugier P, Schiano de Colella JM, Tilly H, Palomba ML, Bachy E, Fruchart C, Libby EN, Casasnovas RO, Flinn IW, Haioun C, Maisonneuve H, Ysebaert L, Bartlett NL, Bouabdallah K, Brice P, Ribrag V, Le Gouill S, Daguindau N, Guidez S, Pica GM, García-Sancho AM, López-Guillermo A, Larouche JF, Ando K, Gomes da Silva M, André M, Kalung W, Sehn LH, Izutsu K, Cartron G, Gkasiamis A, Crowe R, Xerri L, Fowler NH, Salles G. PMID: 35947804; PMCID: PMC9553375.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    8. Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma. N Engl J Med. 2022 07 14; 387(2):132-147. Richardson PG, Jacobus SJ, Weller EA, Hassoun H, Lonial S, Raje NS, Medvedova E, McCarthy PL, Libby EN, Voorhees PM, Orlowski RZ, Anderson LD, Zonder JA, Milner CP, Gasparetto C, Agha ME, Khan AM, Hurd DD, Gowin K, Kamble RT, Jagannath S, Nathwani N, Alsina M, Cornell RF, Hashmi H, Campagnaro EL, Andreescu AC, Gentile T, Liedtke M, Godby KN, Cohen AD, Openshaw TH, Pasquini MC, Giralt SA, Kaufman JL, Yee AJ, Scott E, Torka P, Foley A, Fulciniti M, Hebert K, Samur MK, Masone K, Maglio ME, Zeytoonjian AA, Nadeem O, Schlossman RL, Laubach JP, Paba-Prada C, Ghobrial IM, Perrot A, Moreau P, Avet-Loiseau H, Attal M, Anderson KC, Munshi NC, DETERMINATION Investigators. PMID: 35660812; PMCID: PMC10040899.
      View in: PubMed   Mentions: 129     Fields:    Translation:HumansCTClinical Trials
    9. Health-related quality of life in patients with light chain amyloidosis treated with bortezomib, cyclophosphamide, and dexamethasone ± daratumumab: Results from the ANDROMEDA study. Am J Hematol. 2022 06 01; 97(6):719-730. Sanchorawala V, Palladini G, Minnema MC, Jaccard A, Lee HC, Gibbs S, Mollee P, Venner C, Lu J, Schönland S, Gatt M, Suzuki K, Kim K, Cibeira MT, Beksac M, Libby E, Valent J, Hungria V, Wong SW, Rosenzweig M, Bumma N, Chauveau D, Gries KS, Fastenau J, Tran NP, Qin X, Vasey SY, Weiss BM, Vermeulen J, Ho KF, Merlini G, Comenzo RL, Kastritis E, Wechalekar AD. PMID: 35293006.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    10. Diagnosis and Management of Multiple Myeloma: A Review. JAMA. 2022 Feb 01; 327(5):464-477. Cowan AJ, Green DJ, Kwok M, Lee S, Coffey DG, Holmberg LA, Tuazon S, Gopal AK, Libby EN. PMID: 35103762.
      View in: PubMed   Mentions: 294     Fields:    Translation:Humans
    11. Dose-dense brentuximab vedotin plus ifosfamide, carboplatin, and etoposide for second-line treatment of relapsed or refractory classical Hodgkin lymphoma: a single centre, phase 1/2 study. Lancet Haematol. 2021 Aug; 8(8):e562-e571. Lynch RC, Cassaday RD, Smith SD, Fromm JR, Cowan AJ, Warren EH, Shadman MS, Shustov A, Till BG, Ujjani CS, Libby EN, Philip M, Coye H, Martino CN, Bhark SL, Morris K, Rasmussen H, Behnia S, Voutsinas J, Gopal AK. PMID: 34329577; PMCID: PMC8457616.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    12. Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis. N Engl J Med. 2021 07 01; 385(1):46-58. Kastritis E, Palladini G, Minnema MC, Wechalekar AD, Jaccard A, Lee HC, Sanchorawala V, Gibbs S, Mollee P, Venner CP, Lu J, Schönland S, Gatt ME, Suzuki K, Kim K, Cibeira MT, Beksac M, Libby E, Valent J, Hungria V, Wong SW, Rosenzweig M, Bumma N, Huart A, Dimopoulos MA, Bhutani D, Waxman AJ, Goodman SA, Zonder JA, Lam S, Song K, Hansen T, Manier S, Roeloffzen W, Jamroziak K, Kwok F, Shimazaki C, Kim JS, Crusoe E, Ahmadi T, Tran N, Qin X, Vasey SY, Tromp B, Schecter JM, Weiss BM, Zhuang SH, Vermeulen J, Merlini G, Comenzo RL, ANDROMEDA Trial Investigators. PMID: 34192431.
      View in: PubMed   Mentions: 156     Fields:    Translation:HumansCTClinical Trials
    13. Prolonged Lenalidomide Therapy Does Not Impact Autologous Peripheral Blood Stem Cell Mobilization and Collection in Multiple Myeloma Patients: A Single-Center Retrospective Analysis. Transplant Cell Ther. 2021 08; 27(8):661.e1-661.e6. Cowan AJ, Stevenson PA, Green DJ, Tuazon S, Libby EN, Kwok M, Lee S, Coffey DG, Gopal AK, Holmberg LA. PMID: 33895403.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    14. High-Throughput Drug Screening and Multi-Omic Analysis to Guide Individualized Treatment for Multiple Myeloma. JCO Precis Oncol. 2021; 5. Coffey DG, Cowan AJ, DeGraaff B, Martins TJ, Curley N, Green DJ, Libby EN, Silbermann R, Chien S, Dai J, Morales A, Gooley TA, Warren EH, Becker PS. PMID: 34250400; PMCID: PMC8232547.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    15. Evaluation of Cardiac Repolarization in the Randomized Phase 2 Study of Intermediate- or High-Risk Smoldering Multiple Myeloma Patients Treated with Daratumumab Monotherapy. Adv Ther. 2021 02; 38(2):1328-1341. Chari A, Munder M, Weisel K, Jenner M, Bygrave C, Petrucci MT, Boccadoro M, Cavo M, van de Donk NWCJ, Turgut M, Demirkan F, Karadogan I, Libby E, Kleiman R, Kuppens S, Bandekar R, Neff T, Heuck C, Qi M, Clemens PL, Goldschmidt H. PMID: 33474705; PMCID: PMC7889563.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    16. Assessment of Left Ventricular, Right Ventricular, and Left Atrial Strain in Light-Chain Amyloidosis. JACC CardioOncol. 2020 Nov; 2(4):647-649. Leedy DJ, Vasbinder A, Huang HD, Fernandes R, Cowan AJ, Gopal AK, Kirkpatrick JN, Libby EN, Cheng RK. PMID: 33511354; PMCID: PMC7839948.
      View in: PubMed   Mentions: 2  
    17. A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study. Blood. 2020 10 29; 136(18):2038-2050. Tam CS, Opat S, D'Sa S, Jurczak W, Lee HP, Cull G, Owen RG, Marlton P, Wahlin BE, Sanz RG, McCarthy H, Mulligan S, Tedeschi A, Castillo JJ, Czyz J, Fernández de Larrea C, Belada D, Libby E, Matous JV, Motta M, Siddiqi T, Tani M, Trneny M, Minnema MC, Buske C, Leblond V, Trotman J, Chan WY, Schneider J, Ro S, Cohen A, Huang J, Dimopoulos M. PMID: 32731259; PMCID: PMC7596850.
      View in: PubMed   Mentions: 177     Fields:    Translation:HumansCTClinical Trials
    18. Multicenter phase 2 study of daratumumab monotherapy in patients with previously treated Waldenström macroglobulinemia. Blood Adv. 2020 10 27; 4(20):5089-5092. Castillo JJ, Libby EN, Ansell SM, Palomba ML, Meid K, Flynn CA, Leventoff C, Hergott CB, Sewastianik T, Morgan EA, Carrasco R, Fromm JR, Yang G, Hunter Z, Treon SP. PMID: 33085756; PMCID: PMC7594378.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    19. The Global State of Hematopoietic Cell Transplantation for Multiple Myeloma: An Analysis of the Worldwide Network of Blood and Marrow Transplantation Database and the Global Burden of Disease Study. Biol Blood Marrow Transplant. 2020 12; 26(12):2372-2377. Cowan AJ, Baldomero H, Atsuta Y, Mikhael J, Aljurf M, Seber A, Greinix H, Koh M, Worel N, Libby EN, Pasquini M, Galeano S, Saber W, Iida M, Jaimovich G, Rolon JM, Kodera Y, Benakli M, Nosa BG, Elhaddad A, Szer J, Passweg J, Kroeger N, Weisdorf D, Niederwieser D. PMID: 32846200; PMCID: PMC7767639.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    20. Considerations for Managing Patients With Hematologic Malignancy During the COVID-19 Pandemic: The Seattle Strategy. JCO Oncol Pract. 2020 09; 16(9):571-578. Percival MM, Lynch RC, Halpern AB, Shadman M, Cassaday RD, Ujjani C, Shustov A, Tseng YD, Liu C, Pergam S, Libby EN, Scott BL, Smith SD, Green DJ, Gopal AK, Cowan AJ. PMID: 32369409; PMCID: PMC7489485.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCellsPHPublic Health
    21. KRD-PACE Mobilization for Multiple Myeloma Patients With Significant Residual Disease Before Autologous Stem-Cell Transplantation. Clin Lymphoma Myeloma Leuk. 2020 09; 20(9):602-609. Cowan AJ, Green DJ, Karami M, Becker PS, Tuazon S, Coffey DG, Hyun TS, Libby EN, Gopal AK, Holmberg LA. PMID: 32457024.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    22. Recent Advances in the Treatment Of Newly Diagnosed Multiple Myeloma. J Adv Pract Oncol. 2020 Apr; 11(3):301-305. Libby E, Epworth J. PMID: 33598330; PMCID: PMC7857329.
      View in: PubMed   Mentions:
    23. Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study. Lancet Oncol. 2020 02; 21(2):207-221. Lonial S, Lee HC, Badros A, Trudel S, Nooka AK, Chari A, Abdallah AO, Callander N, Lendvai N, Sborov D, Suvannasankha A, Weisel K, Karlin L, Libby E, Arnulf B, Facon T, Hulin C, Kortüm KM, Rodríguez-Otero P, Usmani SZ, Hari P, Baz R, Quach H, Moreau P, Voorhees PM, Gupta I, Hoos A, Zhi E, Baron J, Piontek T, Lewis E, Jewell RC, Dettman EJ, Popat R, Esposti SD, Opalinska J, Richardson P, Cohen AD. PMID: 31859245.
      View in: PubMed   Mentions: 325     Fields:    Translation:HumansCTClinical Trials
    24. The incidence of thromboembolism for lenalidomide versus thalidomide in older patients with newly diagnosed multiple myeloma. Ann Hematol. 2020 Jan; 99(1):121-126. Li A, Wu Q, Warnick G, Li S, Libby EN, Garcia DA, Lyman GH. PMID: 31773215.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    25. Bortezomib and Vorinostat Therapy as Maintenance Therapy after Autologous Transplant for Multiple Myeloma. Acta Haematol. 2020; 143(2):146-154. Holmberg LA, Green D, Libby E, Becker PS. PMID: 31434076.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    26. Derivation and Validation of a Risk Assessment Model for Immunomodulatory Drug-Associated Thrombosis Among Patients With Multiple Myeloma. J Natl Compr Canc Netw. 2019 07 01; 17(7):840-847. Li A, Wu Q, Luo S, Warnick GS, Zakai NA, Libby EN, Gage BF, Garcia DA, Lyman GH, Sanfilippo KM. PMID: 31319391; PMCID: PMC7808759.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    27. Antibody-drug conjugate, GSK2857916, in relapsed/refractory multiple myeloma: an update on safety and efficacy from dose expansion phase I study. Blood Cancer J. 2019 03 20; 9(4):37. Trudel S, Lendvai N, Popat R, Voorhees PM, Reeves B, Libby EN, Richardson PG, Hoos A, Gupta I, Bragulat V, He Z, Opalinska JB, Cohen AD. PMID: 30894515; PMCID: PMC6426965.
      View in: PubMed   Mentions: 112     Fields:    Translation:HumansCTClinical Trials
    28. A pilot study of weekly brentuximab vedotin in patients with CD30+ malignancies resistant to brentuximab vedotin every 3 weeks. Br J Haematol. 2019 07; 186(1):159-162. Poston JN, Fromm JR, Rasmussen HA, Shustov AR, Libby EN, Smith SD, Gooley T, Gopal AK. PMID: 30592026; PMCID: PMC6589112.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    29. Triplet therapies - the new standard of care for multiple myeloma: how to manage common toxicities. Expert Rev Hematol. 2018 12; 11(12):957-973. Paner A, Okwuosa TM, Richardson KJ, Libby EN. PMID: 30339769.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    30. Targeting B-cell maturation antigen with GSK2857916 antibody-drug conjugate in relapsed or refractory multiple myeloma (BMA117159): a dose escalation and expansion phase 1 trial. Lancet Oncol. 2018 12; 19(12):1641-1653. Trudel S, Lendvai N, Popat R, Voorhees PM, Reeves B, Libby EN, Richardson PG, Anderson LD, Sutherland HJ, Yong K, Hoos A, Gorczyca MM, Lahiri S, He Z, Austin DJ, Opalinska JB, Cohen AD. PMID: 30442502; PMCID: PMC6328058.
      View in: PubMed   Mentions: 134     Fields:    Translation:HumansCellsCTClinical Trials
    31. Bendamustine with rituximab, etoposide and carboplatin (T(R)EC) in relapsed or refractory aggressive lymphoma: a prospective multicentre phase 1/2 clinical trial. Br J Haematol. 2018 11; 183(4):601-607. Budde LE, Wu D, Martin DB, Philip M, Shustov AR, Smith SD, Gooley TA, Chen TL, Libby EN, Chen EY, Kojouri K, Langerak A, Roden JE, Press OW, Gopal AK. PMID: 30596402; PMCID: PMC6314205.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    32. Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma. N Engl J Med. 2018 09 06; 379(10):934-947. Morschhauser F, Fowler NH, Feugier P, Bouabdallah R, Tilly H, Palomba ML, Fruchart C, Libby EN, Casasnovas RO, Flinn IW, Haioun C, Maisonneuve H, Ysebaert L, Bartlett NL, Bouabdallah K, Brice P, Ribrag V, Daguindau N, Le Gouill S, Pica GM, Martin Garcia-Sancho A, López-Guillermo A, Larouche JF, Ando K, Gomes da Silva M, André M, Zachée P, Sehn LH, Tobinai K, Cartron G, Liu D, Wang J, Xerri L, Salles GA, RELEVANCE Trial Investigators. PMID: 30184451; PMCID: PMC11003525.
      View in: PubMed   Mentions: 123     Fields:    Translation:HumansCTClinical Trials
    33. Global Burden of Multiple Myeloma: A Systematic Analysis for the Global Burden of Disease Study 2016. JAMA Oncol. 2018 09 01; 4(9):1221-1227. Cowan AJ, Allen C, Barac A, Basaleem H, Bensenor I, Curado MP, Foreman K, Gupta R, Harvey J, Hosgood HD, Jakovljevic M, Khader Y, Linn S, Lad D, Mantovani L, Nong VM, Mokdad A, Naghavi M, Postma M, Roshandel G, Shackelford K, Sisay M, Nguyen CT, Tran TT, Xuan BT, Ukwaja KN, Vollset SE, Weiderpass E, Libby EN, Fitzmaurice C. PMID: 29800065; PMCID: PMC6143021.
      View in: PubMed   Mentions: 264     Fields:    Translation:Humans
    34. Plasma cell diseases and organ transplant: A comprehensive review. Am J Transplant. 2018 05; 18(5):1046-1058. Cowan AJ, Johnson CK, Libby EN. PMID: 29524307.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    35. Circulating Plasma Cells at the Time of Collection of Autologous PBSC for Transplant in Multiple Myeloma Patients is a Negative Prognostic Factor Even in the Age of Post-Transplant Maintenance Therapy. Biol Blood Marrow Transplant. 2018 07; 24(7):1386-1391. Cowan AJ, Stevenson PA, Libby EN, Becker PS, Coffey DG, Green DJ, Hyun TS, Fromm JR, Gopal AK, Holmberg LA. PMID: 29481870.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    36. Pre-transplantation novel agent induction predicts progression-free survival for patients with immunoglobulin light-chain amyloidosis undergoing high-dose melphalan and autologous stem cell transplantation. Amyloid. 2016 Dec; 23(4):254-259. Cowan AJ, Klippel ZK, Stevenson PA, Hyun TS, Tuazon S, Becker PS, Green DJ, Holmberg LA, Coffey DG, Gopal AK, Libby EN. PMID: 27879147; PMCID: PMC5189710.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    37. Ricolinostat plus lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: a multicentre phase 1b trial. Lancet Oncol. 2016 Nov; 17(11):1569-1578. Yee AJ, Bensinger WI, Supko JG, Voorhees PM, Berdeja JG, Richardson PG, Libby EN, Wallace EE, Birrer NE, Burke JN, Tamang DL, Yang M, Jones SS, Wheeler CA, Markelewicz RJ, Raje NS. PMID: 27646843.
      View in: PubMed   Mentions: 91     Fields:    Translation:HumansCTClinical Trials
    38. A phase II randomized trial comparing standard and low dose rituximab combined with alemtuzumab as initial treatment of progressive chronic lymphocytic leukemia in older patients: a trial of the ECOG-ACRIN cancer research group (E1908). Am J Hematol. 2016 Mar; 91(3):308-12. Zent CS, Victoria Wang X, Ketterling RP, Hanson CA, Libby EN, Barrientos JC, Call TG, Chang JE, Liu JJ, Calvo AR, Lazarus HM, Rowe JM, Luger SM, Litzow MR, Tallman MS. PMID: 26662208; PMCID: PMC4806550.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    39. High-dose CD20-targeted radioimmunotherapy-based autologous transplantation improves outcomes for persistent mantle cell lymphoma. Br J Haematol. 2015 Dec; 171(5):788-97. Cassaday RD, Stevenson PA, Gooley TA, Chauncey TR, Pagel JM, Rajendran J, Till BG, Philip M, Orozco JJ, Bensinger WI, Holmberg LA, Shustov AR, Green DJ, Smith SD, Libby EN, Maloney DG, Press OW, Gopal AK. PMID: 26455717; PMCID: PMC4715476.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    40. Pretransplantation Minimal Residual Disease Predicts Survival in Patients with Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation in Complete Remission. Biol Blood Marrow Transplant. 2016 Feb; 22(2):380-385. Cowan AJ, Stevenson PA, Cassaday RD, Graf SA, Fromm JR, Wu D, Holmberg LA, Till BG, Chauncey TR, Smith SD, Philip M, Orozco JJ, Shustov AR, Green DJ, Libby EN, Bensinger WI, Shadman M, Maloney DG, Press OW, Gopal AK. PMID: 26348890; PMCID: PMC4716882.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    41. Phase Ib/II trial of CYKLONE (cyclophosphamide, carfilzomib, thalidomide and dexamethasone) for newly diagnosed myeloma. Br J Haematol. 2015 Apr; 169(2):219-27. Mikhael JR, Reeder CB, Libby EN, Costa LJ, Bergsagel PL, Buadi F, Mayo A, Nagi Reddy SK, Gano K, Dueck AC, Stewart AK. PMID: 25683772; PMCID: PMC4521972.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    42. Panobinostat: a review of trial results and future prospects in multiple myeloma. Expert Rev Hematol. 2015 Feb; 8(1):9-18. Libby EN, Becker PS, Burwick N, Green DJ, Holmberg L, Bensinger WI. PMID: 25410127.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    43. Brentuximab vedotin administered to platinum-refractory, transplant-naïve Hodgkin lymphoma patients can increase the proportion achieving FDG PET negative status. Hematol Oncol. 2015 Dec; 33(4):187-91. Onishi M, Graf SA, Holmberg L, Behnia S, Shustov AR, Schiavo K, Philip M, Libby EN, Cassaday RD, Pagel JM, Roden JE, Maloney DG, Green DJ, Till BG, Press OW, Smith SD, Gopal AK. PMID: 25236531; PMCID: PMC4366342.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    44. Autologous transplant for relapsed follicular lymphoma: impact of pre-transplant rituximab sensitivity. Leuk Lymphoma. 2015 Jan; 56(1):92-6. Phipps C, Gopal AK, Storer BE, Cassaday RD, Press OW, Till BG, Pagel JM, Palanca-Wessels MC, Philip M, Bensinger WI, Holmberg LA, Shustov AR, Green DJ, Chauncey T, Maloney DG, Libby EN. PMID: 24707941; PMCID: PMC4269586.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    45. Disease-specific survival for patients with multiple myeloma: significant improvements over time in all age groups. Leuk Lymphoma. 2014 Dec; 55(12):2850-7. Libby E, Garcia D, Quintana D, Fekrazad MH, Bauman J, Ebaid A, Hromas R, Rabinowitz I, Wiggins C. PMID: 24588734.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    46. Specific features identify patients with relapsed or refractory mantle cell lymphoma benefitting from autologous hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2013 Sep; 19(9):1403-6. Cassaday RD, Guthrie KA, Budde EL, Thompson L, Till BG, Press OW, Chauncey TR, Pagel JM, Petersdorf SH, Palanca-Wessels MC, Philip M, Bensinger WI, Holmberg LA, Shustov A, Green DJ, Libby EN, Maloney DG, Gopal AK. PMID: 23871782; PMCID: PMC3788600.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    47. Dismounting the MDR horse. Blood. 2010 Nov 18; 116(20):4037-8. Libby E, Hromas R. PMID: 21088139.
      View in: PubMed   Mentions: 18     Fields:    
    48. Cytomegalovirus retinitis during chemotherapy with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone. J Clin Oncol. 2010 Nov 10; 28(32):e661-2. Libby E, Movva S, Quintana D, Abdul-Jaleel M, Das A. PMID: 20855824.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    49. Durable complete remission of primary plasma cell leukemia with the bortezomib plus melphalan and prednisone (VMP) regimen. Am J Hematol. 2010 Sep; 85(9):733-4. Libby E, Candelaria-Quintana D, Moualla H, Abdul-Jaleel M, Rabinowitz I. PMID: 20669178.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    50. Age disparity in the dissemination of imatinib for treating chronic myeloid leukemia. Am J Med. 2010 Aug; 123(8):764.e1-9. Wiggins CL, Harlan LC, Nelson HE, Stevens JL, Willman CL, Libby EN, Hromas RA. PMID: 20670732; PMCID: PMC2913144.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    51. Is patient self-testing a good thing? J Thromb Thrombolysis. 2010 Feb; 29(2):214-8. Oertel LB, Libby EN. PMID: 19902148.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    52. Tumor MET expression may not predict the risk of venous thromboembolism in cancer patients. Oncol Res. 2010; 19(2):93-7. Sayar H, Bunning JT, Bocklage TJ, Lee SJ, Libby E, Rabinowitz I. PMID: 21302810.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    53. The new oral anticoagulants. Blood. 2010 Jan 07; 115(1):15-20. Garcia D, Libby E, Crowther MA. PMID: 19880491.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    54. A prospective, controlled trial of a pharmacy-driven alert system to increase thromboprophylaxis rates in medical inpatients. Blood Coagul Fibrinolysis. 2009 Oct; 20(7):541-5. Garcia DA, Highfill J, Finnerty K, Varoz E, McConkey S, Hutchinson K, Libby E. PMID: 19584716.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    55. Metnase mediates chromosome decatenation in acute leukemia cells. Blood. 2009 Aug 27; 114(9):1852-8. Wray J, Williamson EA, Sheema S, Lee SH, Libby E, Willman CL, Nickoloff JA, Hromas R. PMID: 19458360; PMCID: PMC2738570.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCells
    56. Rate of thromboembolic events in mesothelioma. Ann Thorac Surg. 2008 Mar; 85(3):1032-8. Nguyen D, Lee SJ, Libby E, Verschraegen C. PMID: 18291192.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    57. False-negative factor V Leiden genetic testing in a patient with recurrent deep venous thrombosis. Am J Hematol. 2006 Apr; 81(4):284-9. Libby EN, Booker JK, Gulley ML, Garcia D, Moll S. PMID: 16550515.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    58. Update on the diagnosis and management of pulmonary embolism. Br J Haematol. 2005 Nov; 131(3):301-12. Garcia D, Ageno W, Libby E. PMID: 16225649.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    59. Life-threatening abdominal wall hematoma in a chronic renal failure patient after a single dose of enoxaparin. Am Surg. 2005 Feb; 71(2):132-4. Weinsheimer RL, Libby E, Howdieshell TR. PMID: 16022012.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    60. Perioperative anticoagulation for patients with mechanical heart valves: a survey of current practice. J Thromb Thrombolysis. 2004 Dec; 18(3):199-203. Garcia DA, Ageno W, Libby EN, Bibb J, Douketis J, Crowther MA. PMID: 15815882.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    61. Managing oral anticoagulant therapy in patients with mechanical heart valves undergoing elective surgery: results of a survey conducted among Italian physicians. Blood Coagul Fibrinolysis. 2004 Oct; 15(8):623-8. Ageno W, Garcia D, Libby E, Crowther MA. PMID: 15613916.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    62. A survey of oral vitamin K use by anticoagulation clinics. Arch Intern Med. 2002 Sep 09; 162(16):1893-6. Libby EN, Garcia DA. PMID: 12196089.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    Edward's Networks
    Concepts (262)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (2)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version UCSF-v3.1.0-6-g69de2244 on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California